U.S. pharma big copyright scrapped two experimental weight loss products previous calendar year—a the moment-daily capsule, lotiglipron, because of elevated liver enzymes plus a 2 times-daily capsule, danuglipron, on account of solid Negative effects—but CEO Albert Bourla has explained the company is set to “Engage in and gain” in the weigh